Company Filing History:
10 out of 263 
1 out of 230 
Years Active: 2019-2024
Title: Bohdan Waszkowycz: Innovator in Pharmaceutical Compounds
Introduction
Bohdan Waszkowycz is a prominent inventor based in Manchester, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific enzyme activities. With a total of 10 patents to his name, his work has implications for the treatment of various proliferative disorders, including cancer.
Latest Patents
Among his latest patents, Waszkowycz has developed PARG inhibitory compounds. This invention relates to compounds that function as inhibitors of the PARG (Poly ADP-ribose glycohydrolase) enzyme activity. The compounds are designed to be used in pharmaceutical compositions for treating diseases where PARG activity is implicated. Another notable patent involves compounds useful as RET inhibitors, which target the RET (rearranged during transfection) kinase enzyme activity. These compounds also have potential applications in treating proliferative disorders and other conditions associated with RET kinase activity.
Career Highlights
Throughout his career, Waszkowycz has worked with notable organizations such as Cancer Research Technology Limited and GlaxoSmithKline Intellectual Property Development Limited. His experience in these companies has allowed him to advance his research and contribute to the development of innovative pharmaceutical solutions.
Collaborations
Waszkowycz has collaborated with several professionals in his field, including Allan Michael Jordan and Rebecca Newton. These collaborations have further enriched his research and development efforts.
Conclusion
Bohdan Waszkowycz is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact the treatment of serious health conditions. His innovative patents and collaborations highlight his commitment to advancing medical science.